X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/torrent-zydus-in-co-marketing-pact-for-liver-disease-drug-saroglitazar/articleshow/105124905.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-starts-trial-to-generate-data-on-effect-of-saroglitazar-mg-in-nafld-patients/articleshow/100874481.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.indianpharmapost.com/news/nafld-clinical-trial-activity-catching-up-in-china-but-lacks-substantial-domestic-participation-says-globaldata-13507
https://www.expresspharma.in/zydus-announces-epics-iiitm-phase-iib-iii-adaptive-pivotal-clinical-trial-of-saroglitazar-mg-in-pbc/
https://www.expresspharma.in/zydus-announces-epics-iiitm-phase-iib-iii-adaptive-pivotal-clinical-trial-of-saroglitazar-mg-in-pbc/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/european-medicines-agency-grants-orphan-drug-designation-to-zydus-cadilas-saroglitazar-mg/articleshow/84610016.cms
https://www.zyduscadila.com/public/pdf/pressrelease/Zydus_announces_the_approval_of_Saroglitazar_Mg_for_the_treatment_of_Non_Alcoholic_Fatty_Liver_Disease_in_India_30_12_2020.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-receives-dcgi-nod-for-nafld-drug-saroglitazar-mg-in-india/articleshow/80022275.cms
https://www.expresspharma.in/latest-updates/zydus-to-present-pbc-and-nash-clinical-trial-data-of-saroglitazar-mg-at-aasld-event/
https://www.prnewswire.com/news-releases/zydus-announces-worlds-first-drug-for-the-treatment-of-non-cirrhotic-nash-301017439.html
https://www.moneycontrol.com/news/business/companies/cadila-healthcare-files-nda-of-saroglitazar-mg-with-dcgi-targeting-liver-diseases-4703181.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-files-nda-for-saroglitazar-magnesium/articleshow/72379297.cms
https://www.biospace.com/article/releases/zydus-announces-positive-results-from-evidences-iv-phase-2-clinical-trial-of-saroglitazar-magnesium-in-nafld-and-nash/?s=62
https://www.prnewswire.com/news-releases/zydus-announces-regulatory-approval-of-lipaglyn-saroglitazar-magnesium-in-mexico-656603783.html
http://www.indiainfoline.com/article/news-top-story/cadila-healthcare-cadila-healthcare-receives-approval-from-usfda-117022300297_1.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/how-top-indian-drug-makers-like-sun-pharma-glenmark-are-building-a-brands-business-in-the-us/articleshow/56382828.cms
http://www.fiercepharma.com/marketing/fda-promo-police-slap-four-more-pharmas-year-end-enforcement-spree
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-fda-pulls-up-cadila-for-misbranding-drug/articleshow/56226550.cms
http://www.business-standard.com/article/news-cm/cadila-healthcare-gains-ahead-of-presenting-new-data-of-saroglitazar-116110100154_1.html
http://www.fiercepharmaasia.com/story/indias-gliptin-market-ready-shakeup-zydus-11-us-cents-pill/2015-11-23
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-launches-tenglyn-tablets-in-indian-market/articleshow/49861557.cms
http://www.business-standard.com/article/companies/zydus-to-start-phase-ii-clinical-trials-for-saroglitazar-in-us-115111800370_1.html
http://www.dnaindia.com/money/report-zydus-gets-us-fda-nod-for-clinical-trials-of-sarolitazar-2146461
Market Place
Share 
